These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4033069)

  • 1. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays.
    Press MF; Holt JA; Herbst AL; Greene GL
    Lab Invest; 1985 Sep; 53(3):349-61. PubMed ID: 4033069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin.
    Press MF; Greene GL
    Lab Invest; 1984 Apr; 50(4):480-6. PubMed ID: 6368973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer.
    Masood S
    Cancer Detect Prev; 1988; 12(1-6):283-90. PubMed ID: 3052833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
    McCarty KS; Szabo E; Flowers JL; Cox EB; Leight GS; Miller L; Konrath J; Soper JT; Budwit DA; Creasman WT
    Cancer Res; 1986 Aug; 46(8 Suppl):4244s-4248s. PubMed ID: 3524805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
    Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
    J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.
    Charpin C; Martin PM; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Toga M
    Cancer Res; 1986 Aug; 46(8 Suppl):4271s-4277s. PubMed ID: 3524808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
    Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
    Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies.
    Press MF; Nousek-Goebl NA; Greene GL
    J Histochem Cytochem; 1985 Sep; 33(9):915-24. PubMed ID: 4020102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
    Richman CM; Holt JA; Lorincz MA; Herbst AL
    Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle.
    Press MF; Nousek-Goebl N; King WJ; Herbst AL; Greene GL
    Lab Invest; 1984 Nov; 51(5):495-503. PubMed ID: 6387273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.
    King WJ; DeSombre ER; Jensen EV; Greene GL
    Cancer Res; 1985 Jan; 45(1):293-304. PubMed ID: 3965140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor immunocytochemical assay (ER-ICA) in human endometrium.
    Charpin C; Martin PM; Lavaut MN; Pourreau-Schneider N; Toga M
    Int J Gynecol Pathol; 1986; 5(2):119-31. PubMed ID: 3522449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.
    Budwit-Novotny DA; McCarty KS; Cox EB; Soper JT; Mutch DG; Creasman WT; Flowers JL; McCarty KS
    Cancer Res; 1986 Oct; 46(10):5419-25. PubMed ID: 3756890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody.
    Flowers JL; Seigler HF; McCarty KS; Konrath J; McCarty KS
    Arch Dermatol; 1987 Jun; 123(6):764-5. PubMed ID: 3555354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor localization in the female genital tract.
    Press MF; Nousek-Goebl NA; Bur M; Greene GL
    Am J Pathol; 1986 May; 123(2):280-92. PubMed ID: 2939725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
    Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
    Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.